ARISg and ARISj: Extending a Worldwide Pharmacovigilance Program into the Japanese Market – White paper

Mar 4, 2016

An integrated safety and pharmacovigilance system with worldwide business processes helps companies realize significant productivity benefits. This position paper summarizes Aris Global’s Total Safety global solution for companies that are either headquartered in Japan or have Japanese affiliates and focuses on the key benefits of deploying a single safety and pharmacovigilance system.

(*) denotes required filed
* First Name :
* Last Name :
* Business Email :
Organization Name :
* Phone :
* Country :
* city :
* Which best describes your current need? :
Please provide us with any additional details regarding your needs
:
Please have someone call me about this Whitepaper:

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Alberto Cantor
ArisGlobal
+1 609-360-4042 | acantor@arisglobal.com